Blood Pressure

Cardiovascular risk stratification: an important tool for treatment to lower cardiovascular disease risk
pp. 125-126(2)
Authors: Himmelmann A.; Kjeldsen S.; Hedner T.

The nature of essential hypertension: still a cognitive maze
pp. 127-136(10)
Authors: Birkenhäger W.

Cardiovascular events in elderly patients with isolated systolic hypertension. A subgroup analysis of treatment strategies in STOP-Hypertension-2
pp. 137-141(5)
Authors: Ekbom T.; Linjer E.; Hedner T.; Lanke J.; de Faire U.; Wester P.-O.; Dahlöf B.; Scherstén B.

Cardiovascular risk stratification according to the 2003 ESH-ESC guidelines in uncomplicated patients with essential hypertension: comparison with the 1999 WHO/ISH guidelines criteria
pp. 142-151(10)
Authors: Cuspidi C.; Meani S.; Salerno M.; Severgnini B.; Fusi V.; Valerio C.; Catini E.; Magrini F.; Zanchetti A.

A single nucleotide polymorphism in the promoter region of the osteoprotegerin gene is related to intima-media thickness of the carotid artery in hypertensive patients. The Swedish irbesartan left ventricular hypertrophy investigation vs atenolol (SILVHIA)
pp. 152-157(6)
Authors: Brändström H.; Stiger F.; Kahan T.; Melhus H.; Nyström F.; Öhman K.P.; Malmqvist K.; Lind L.; Kindmark A.

Association of -344/T/C aldosterone synthase polymorphism (CYP11B2) with left ventricular structure and humoral parameters in young normotensive men
pp. 158-163(6)
Authors: Heller S.; Linhart A.; Jindra A.; Jáchymová M.; Horký K.; Peleka J.; Hlubocká Z.; Umnerová V.; Aschermann M.

Does blood pressure change in treated hypertensive patients depending on whether it is measured by a physician or a nurse?
pp. 164-168(5)
Authors: Coll de Tuero G.; Sanmartin Albertos M.; Vargas Vila S.; Trèmols Iglesias S.; Saez Zafra M.; Barceló Rado A.

Geographical differences in blood pressure of male youth aged 17-21 years in China
pp. 169-175(7)
Authors: Lei S.; Yong-Yong X.; Xiao-Han D.; Chang-Sheng C.

Decreasing population blood pressure: 15 years of follow-up in the Copenhagen City Heart Study (CCHS)
pp. 176-182(7)
Authors: Andersen U.O.; Jensen G.

Effects of losartan versus hydrochlorothiazide on indices of endothelial damage/dysfunction, angiogenesis and tissue factor in essential hypertension
pp. 183-189(7)
Authors: Chung N.A.; Beevers D.G.; Lip G.